Phillip Hwang
Profiles

Phillip Hwang

Assistant Professor (previously held), Epidemiology - Boston University School of Public Health

Biography

Phillip Hwang, PhD, MPH, is an Assistant Professor in the Department of Epidemiology at the Boston University School of Public Health. As a neuroepidemiologist, his primary research focuses on modifiable lifestyle factors, such as physical activity, diet, and social engagement, across the life course on risk and resilience for Alzheimer's disease and related dementias (ADRD). He also conducts research on traumatic brain injury and chronic traumatic encephalopathy, as well as use of digital technologies to assess cognition and facilitate more inclusive and representative research around ADRD.

Education

  • University of Washington, PhD Field of Study: Epidemiology
  • Columbia University, MPH Field of Study: Epidemiology
  • Brown University, BA Field of Study: Biology

Classes Taught

  • SPHEP740
  • SPHEP749

Publications

  • Published on 2/15/2024

    Ding H, Kim M, Searls E, Sunderaraman P, De Anda-Duran I, Low S, Popp Z, Hwang PH, Li Z, Goyal K, Hathaway L, Monteverde J, Rahman S, Igwe A, Kolachalama VB, Au R, Lin H. Digital neuropsychological measures by defense automated neurocognitive assessment: reference values and clinical correlates. Front Neurol. 2024; 15:1340710. PMID: 38426173.

    Read At: PubMed
  • Published on 1/16/2024

    Popp Z, Low S, Igwe A, Rahman MS, Kim M, Khan R, Oh E, Kumar A, De Anda-Duran I, Ding H, Hwang PH, Sunderaraman P, Shih LC, Lin H, Kolachalama VB, Au R. Shifting From Active to Passive Monitoring of Alzheimer Disease: The State of the Research. J Am Heart Assoc. 2024 Jan 16; 13(2):e031247. PMID: 38226518.

    Read At: PubMed
  • Published on 1/16/2024

    Sunderaraman P, De Anda-Duran I, Karjadi C, Peterson J, Ding H, Devine SA, Shih LC, Popp Z, Low S, Hwang PH, Goyal K, Hathaway L, Monteverde J, Lin H, Kolachalama VB, Au R. Design and Feasibility Analysis of a Smartphone-Based Digital Cognitive Assessment Study in the Framingham Heart Study. J Am Heart Assoc. 2024 Jan 16; 13(2):e031348. PMID: 38226510.

    Read At: PubMed
  • Published on 1/16/2024

    Azizi Z, Golbus JR, Spaulding EM, Hwang PH, Ciminelli ALA, Lacar K, Hernandez MF, Gilotra NA, Din N, Brant LCC, Au R, Beaton A, Nallamothu BK, Longenecker CT, Martin SS, Dorsch MP, Sandhu AT. Challenge of Optimizing Medical Therapy in Heart Failure: Unlocking the Potential of Digital Health and Patient Engagement. J Am Heart Assoc. 2024 Jan 16; 13(2):e030952. PMID: 38226520.

    Read At: PubMed
  • Published on 1/16/2024

    De Anda-Duran I, Sunderaraman P, Searls E, Moukaled S, Jin X, Popp Z, Karjadi C, Hwang PH, Ding H, Devine S, Shih LC, Low S, Lin H, Kolachalama VB, Bazzano L, Libon DJ, Au R. Comparing Cognitive Tests and Smartphone-Based Assessment in 2 US Community-Based Cohorts. J Am Heart Assoc. 2024 Jan 16; 13(2):e032733. PMID: 38226519.

    Read At: PubMed
  • Published on 9/29/2023

    Christianson K, Prabhu M, Popp ZT, Rahman MS, Drane J, Lee M, Lathan C, Lin H, Au R, Sunderaraman P, Hwang PH. Adherence type impacts completion rates of frequent mobile cognitive assessments among older adults with and without cognitive impairment. Res Sq. 2023 Sep 29. PMID: 37841867.

    Read At: PubMed
  • Published on 1/19/2023

    Hwang PH, Ang TFA, De Anda-Duran I, Liu X, Liu Y, Gurnani A, Mez J, Auerbach S, Joshi P, Yuan J, Devine S, Au R, Liu C. Examination of potentially modifiable dementia risk factors across the adult life course: The Framingham Heart Study. Alzheimers Dement. 2023 Jul; 19(7):2975-2983. PMID: 36656649.

    Read At: PubMed
  • Published on 1/1/2023

    De Anda-Duran I, Kolachalama VB, Carmichael OT, Hwang PH, Fernandez C, Au R, Bazzano LA, Libon DJ. Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study. J Alzheimers Dis. 2023; 94(1):101-113. PMID: 37212094.

    Read At: PubMed
  • Published on 7/25/2022

    Temkin N, Machamer J, Dikmen S, Nelson LD, Barber J, Hwang PH, Boase K, Stein MB, Sun X, Giacino J, McCrea MA, Taylor SR, Jain S, Manley G. Risk Factors for High Symptom Burden Three Months after Traumatic Brain Injury and Implications for Clinical Trial Design: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. J Neurotrauma. 2022 Nov; 39(21-22):1524-1532. PMID: 35754333.

    Read At: PubMed
  • Published on 6/20/2022

    Qiu S, Miller MI, Joshi PS, Lee JC, Xue C, Ni Y, Wang Y, De Anda-Duran I, Hwang PH, Cramer JA, Dwyer BC, Hao H, Kaku MC, Kedar S, Lee PH, Mian AZ, Murman DL, O'Shea S, Paul AB, Saint-Hilaire MH, Alton Sartor E, Saxena AR, Shih LC, Small JE, Smith MJ, Swaminathan A, Takahashi CE, Taraschenko O, You H, Yuan J, Zhou Y, Zhu S, Alosco ML, Mez J, Stein TD, Poston KL, Au R, Kolachalama VB. Multimodal deep learning for Alzheimer's disease dementia assessment. Nat Commun. 2022 Jun 20; 13(1):3404. PMID: 35725739.

    Read At: PubMed